"10.1371_journal.pone.0108694","plos one","2014-10-06T00:00:00Z","Aaron D Schimmer; Azra Raza; Thomas H Carter; David Claxton; Harry Erba; Daniel J DeAngelo; Martin S Tallman; Carolyn Goard; Gautam Borthakur","Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Columbia University Medical Center, New York, New York, United States of America; The University of Iowa, Iowa City, Iowa, United States of America; Penn State, Hershey, Pennsylvania, United States of America; University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Leukemia Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York, United States of America; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America","Conceived and designed the experiments: ADS GB. Performed the experiments: ADS AR THC DC HE DJD MST CG GB. Analyzed the data: ADS AR THC DC GB. Contributed reagents/materials/analysis tools: ADS AR THC DC HE DJD MST GB. Wrote the paper: ADS AR THC HE DJD MST CG.","The authors have read the journals policy and have the following competing interests: ADS, GB, and THC report research support from GeminX, during the conduct of the study; HE reports compensation from Celgene, Novartis, Celator, Sunesis, Seattle Genetics, and Incyte, outside the submitted work; AR, DC, DJD, CG, and MST have no competing interests to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","10","Aaron D Schimmer","ADS",9,FALSE,2,9,5,7,TRUE,TRUE,FALSE,0,NA,FALSE
